NSCLC lines expressing E-cadherin showed higher sensitivity to EGFR inhibition in vitro and xenografted models, whereas NSCLC lines expressing vimentin and/or fibronectin showed resistance to the growth inhibitory effects of EGFR kinase inhibition (210). This evidence concerns the gene CDH1 and non-small cell lung carcinoma.